1. Controlling cardiac arrhythmias: To delay conduction or to prolong refractoriness

   • Bramah N. Singh

   Antiarrhythmic Agents Pages: 671 - 674

2. Inhibition of calmodulin and protein kinase C by amiodarone and other class III antiarrhythmic agents

   • Paul J. Silver
   • Mary J. Connell
   • Alan M. Ezrin

   Antiarrhythmic Agents Pages: 675 - 682

3. Antiarrhythmic effect of a new class 1 antiarrhythmic drug, AN-132, on ventricular arrhythmias in beagles

   • Keitaro Hashimoto
   • Kozo Watanabe
   • Harumi Mitsuhashi

   Antiarrhythmic Agents Pages: 683 - 689

4. Encainide

   • Michael J. Antonaccio
   • Allen W. Gomoll
   • Jeffrey E. Byrne

   Antiarrhythmic Agents Pages: 691 - 710

5. Effects of cardiovascular disease on pharmacokinetics

   • Vanni Rodighiero

   Reviews Pages: 711 - 730

6. Berpidil: A pharmacological reappraisal of its potential beneficial effects in angina and tissue protection following ischemia

   • R. Massingham
   • P. A. Van Zwieten

   Reviews Pages: 731 - 742

7. The costs of treating hypertension

   • Marvin Moser

   Hypertension Pages: 743 - 747

8. Treating mild hypertension—An unnecessary luxury

   • J. R. Hampton

   Hypertension Pages: 749 - 752

9. Some socioeconomic factors in the selection of blood pressure drugs in New Orleans, Louisiana

   • F. Gilbert McMahon
   • Andrew Johnson
   • William Duncan

   Hypertension Pages: 753 - 755

10. Should the costs of development inhibit research into new antihypertensive drugs?

    • J. I. S. Robertson

    Hypertension Pages: 757 - 759

11. Cost of antihypertensive treatment: A point of view from India

    • Harinder K. Bali
    • Inder S. Anand

    Hypertension Pages: 761 - 765

12. Effects of pindolol and propranolol on blood lipids in hypertensive patients

    • Oscar Román
    • M. Eugenia Pino
    • Angélica Valenzuela

    Hypertension Pages: 767 - 770

13. The vasopressor system in patients with heart failure due to idiopathic dilated cardiomyopathy-influence of the clinical stage of disease and of chronic drug treatment

    • V. Mitrovic
    • J. Thormann
    • M. Schlepper

    Clinical Studies Pages: 771 - 778

14. Imaging of acute myocardial infarction by magnetic resonance tomography (MRT) using the paramagnetic relaxation substance gadolinium-DTPA

    • Hermann W. Eichstaedt
    • Roland Felix
    • Horst Schmutzler

    Clinical Studies Pages: 779 - 788